StockClub
MAZEMaze Therapeutics, Inc.$ --
Maze Therapeutics, Inc.

Maze Therapeutics, Inc.

MAZE

$ -

-

You can review balance sheet highlights, composition, equity ratio trends, and annual balance sheet line items.

account_balanceBalance Sheet (BS) Summary

2024/12 Filed: 2025-03-31

Total Assets

account_balance
240.5M USD
No comparison

Shareholders' Equity

savings
196.9M USD
No comparison

Equity Ratio

pie_chart
81.9%
No comparison

Book Value Per Share

paid
4.09USD
No comparison

Asset & Liability Mix

Non-current AssetsCurrent AssetsEquityNon-current LiabilitiesCurrent Liabilities

Equity Ratio Trend (5 Years)

Unit: %
200150100500
2022
2023
2024

Balance Sheet Details

Item
2022
2023
2024
Cash
Cash and Equivalents
Short-term Investments
Net Receivables
Inventory
Other Current Assets
Total Current Assets
196.81M
196.81M
0
0
0
4.86M
201.67M
Goodwill
Intangible Assets
Property, Plant and Equipment
Property, Plant and Equipment Net
Long-term Investments
Other Assets
Other Non-current Assets
Net Tangible Assets
Non-current Assets Total
Total Assets
0
0
29.92M
29.92M
1.09M
0
7.87M
240.54M
38.87M
240.54M
Accounts Payable
Short-term Debt
Short/Current Long-term Debt
Current Deferred Revenue
Other Current Liabilities
Total Current Liabilities
1.94M
0
0
0
6.02M
20.67M
Long-term Debt
Long-term Debt Total
Capital Lease Obligations
Other Non-current Liabilities
Net Debt
Non-current Liabilities Total
Total Liabilities
0
26.63M
26.63M
969,000
-170.18M
22.96M
43.64M
Common Stock
Common Stock Shares Outstanding
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Other Stockholder Equity
Treasury Stock
Total Stockholder Equity
2,000
43.80M
47.24M
-358.43M
0
0
0
196.90M

Unlock Long-Term Balance Sheet Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.